跳至主要内容
临床试验/NCT02638220
NCT02638220Unknown不适用

An Observational, Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patient Populations Diagnosed With Early-Onset Idiopathic Bilateral Cataracts

Travere Therapeutics, Inc.1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
500
试验地点
1
主要终点
Number of Participants Who Had Positive Genetic Test Results

研究概览

简要总结

This is an observational, multicenter study to determine the prevalence of Cerebrotendinous Xanthomatosis (CTX) in patient populations diagnosed with early-onset idiopathic bilateral cataracts. Patients who are potentially eligible for study participation will be identified through a chart review of patients who were seen at each study site prior to that site's initiation, or by entering care at the site while the site is participating in the trial.

详细描述

This is an observational, multicenter study to determine the prevalence of Cerebrotendinous Xanthomatosis (CTX) in patient populations diagnosed with early-onset idiopathic bilateral cataracts. Patients who are potentially eligible for study participation will be identified through a chart review of patients who were seen at each study site prior to that site's initiation, or by entering care at the site while the site is participating in the trial.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
2 Years 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • The patient has a diagnosis of idiopathic bilateral cataracts.
  • Between the ages of 2 to 21 years at the time of diagnosis

排除标准

  • The patient has a diagnosis of cataracts with known etiology other than CTX.
  • The patient has a diagnosis of CTX.
  • The patient has cataracts caused by cataractogenic treatments.
  • The patient has taken or is currently taking cholic acid or chenodeoxycholic acid.
  • The patient has participated in an interventional clinical trial in the past 30 days.
  • The patient and/or their parent/legal guardian, in the opinion of the Investigator, is unable to adhere to the requirements of the study.

结局指标

主要结局

Number of Participants Who Had Positive Genetic Test Results

时间窗: At genetic testing

genetic test results

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验